Attar M - Search Results

1

Disposition and biotransformation of the acetylenic retinoid tazarotene in humans.

Attar M, Yu D, Ni J, Yu Z, Ling KH, Tang-Liu DD. Attar M, et al. J Pharm Sci. 2005 Oct;94(10):2246-55. doi: 10.1002/jps.20427. J Pharm Sci. 2005. PMID: 16136553 Clinical Trial.

2

Cytochrome P450 2C8 and flavin-containing monooxygenases are involved in the metabolism of tazarotenic acid in humans.

Attar M, Dong D, Ling KH, Tang-Liu DD. Attar M, et al. Drug Metab Dispos. 2003 Apr;31(4):476-81. doi: 10.1124/dmd.31.4.476. Drug Metab Dispos. 2003. PMID: 12642475

3

Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.

Attar M, Shen J, Ling KH, Tang-Liu D. Attar M, et al. Expert Opin Drug Deliv. 2005 Sep;2(5):891-908. doi: 10.1517/17425247.2.5.891. Expert Opin Drug Deliv. 2005. PMID: 16296785 Review.

4

Cytochrome P450 3A expression and activity in the rabbit lacrimal gland: glucocorticoid modulation and the impact on androgen metabolism.

Attar M, Ling KH, Tang-Liu DD, Neamati N, Lee VH. Attar M, et al. Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4697-706. doi: 10.1167/iovs.05-0139. Invest Ophthalmol Vis Sci. 2005. PMID: 16303967

5

Antibody-Drug Conjugate (ADC) Research in Ophthalmology--a Review.

Shen J, Attar M. Shen J, et al. Among authors: attar m. Pharm Res. 2015 Nov;32(11):3572-6. doi: 10.1007/s11095-015-1728-9. Epub 2015 Jun 10. Pharm Res. 2015. PMID: 26058945 Review.

6

Pharmacogenomic considerations in drug delivery.

Attar M, Lee VH. Attar M, et al. Pharmacogenomics. 2003 Jul;4(4):443-61. doi: 10.1517/phgs.4.4.443.22749. Pharmacogenomics. 2003. PMID: 12831323 Review.

7

Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.

Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, Welty D. Chang-Lin JE, et al. Among authors: attar m. Invest Ophthalmol Vis Sci. 2011 Jan 5;52(1):80-6. doi: 10.1167/iovs.10-5285. Invest Ophthalmol Vis Sci. 2011. PMID: 20702826

8

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications.

Shen J, Goodkin ML, Tong W, Attar M. Shen J, et al. Among authors: attar m. Clin Ophthalmol. 2017 Sep 28;11:1761-1767. doi: 10.2147/OPTH.S143428. eCollection 2017. Clin Ophthalmol. 2017. PMID: 29026287 Free PMC article.

9

Design and Conduct Considerations for First-in-Human Trials.

Shen J, Swift B, Mamelok R, Pine S, Sinclair J, Attar M. Shen J, et al. Among authors: attar m. Clin Transl Sci. 2019 Jan;12(1):6-19. doi: 10.1111/cts.12582. Epub 2018 Aug 24. Clin Transl Sci. 2019. PMID: 30048046 Free PMC article.

10

Distribution of ¹⁴C-Latanoprost Following a Single Intracameral Administration Versus Repeated Topical Administration.

Shen J, Moats RA, Pollack HA, Robinson MR, Attar M. Shen J, et al. Among authors: attar m. Ophthalmol Ther. 2020 Dec;9(4):929-940. doi: 10.1007/s40123-020-00285-3. Epub 2020 Aug 1. Ophthalmol Ther. 2020. PMID: 32740740 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters